Catalytic Function:
PfkA is an allosteric enzyme that regulates glycolytic flux through its sensitivity to metabolic effectors like phosphoenolpyruvate (PEP, inhibitor) and ADP (activator) . Unlike its isozyme PfkB (encoded by pfkB), PfkA accounts for 80–95% of total phosphofructokinase activity in E. coli under standard conditions .
The pfkA gene is located at 76 minutes on the E. coli genetic map .
Recombinant PfkA has been synthesized in vitro using plasmid systems (e.g., pLC 16-4), achieving ~30% of the in vivo synthesis efficiency .
| Substrate/Cofactor | Value (Native) | Value (Recombinant) | Conditions | Source |
|---|---|---|---|---|
| Fructose-6-phosphate | pH 7, 75°C | |||
| ATP | pH 8.2, RT | |||
| V<sub>max</sub> (forward) | 360 U/mg | 320 U/mg | 75°C |
Dynamic Knockdown: A pfkA knockdown strain (IB1643) with tunable expression showed near-wild-type growth but redirected carbon flux toward non-glycolytic pathways, enabling enhanced production of compounds like inositol .
Co-utilization of Carbon Sources: Deletion of pfkA and zwf (glucose-6-phosphate dehydrogenase) in E. coli shifted metabolism from the Embden-Meyerhof-Parnas (EMP) pathway to the Entner-Doudoroff (ED) pathway, improving galactose utilization .
Biosynthetic Pathways: Disruption of pfkA in triple mutants (ΔpfkA ΔpfkB Δzwf) enabled novel pathways for dihydroxyacetone (DHA) production via fructose-6-phosphate aldolase (FsaA) .
Antimicrobial Targeting: PfkA suppression in uropathogenic E. coli (UPEC) reduced virulence by altering ATP levels and lipopolysaccharide structure .
KEGG: eck:EC55989_4394